Adjusting Antidepressant Quality Measures for Race and Ethnicity.
Group Health Research Institute, Seattle, Washington.
Gregory E
GE
Simon
Kaiser Permanente Southern California Department of Research and Evaluation, Pasadena.
Karen J
KJ
Coleman
Kaiser Permanente Hawaii Center for Health Research, Honolulu.
Beth E
BE
Waitzfelder
Kaiser Permanente Colorado Institute for Health Research, Denver.
Arne
A
Beck
HealthPartners Institute for Education and Research, Minneapolis, Minnesota.
Rebecca C
RC
Rossom
Group Health Research Institute, Seattle, Washington.
Christine
C
Stewart
Group Health Research Institute, Seattle, Washington.
Robert B
RB
Penfold
D000928:Antidepressive Agents / Q000627:therapeutic use*; D001213:Asian; D003866:Depressive Disorder / Q000188:drug therapy*; D005006:Ethnicity; D054625:Healthcare Disparities / Q000208:ethnology*; D006630:Hispanic or Latino; D006801:Humans; D007198:Indians, North American; D044468:Native Hawaiian or Pacific Islander; D017063:Outcome Assessment, Health Care; D011787:Quality of Health Care; D044469:Racial Groups; D044465:White People
D000928:Antidepressive Agents